Global Medical REIT Inc. Announces Q3 2017 Cash Dividend of $0.20 Per Share

BETHESDA, Md.--()--Global Medical REIT Inc. (NYSE:GMRE) (the “Company”), a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share, today announced that its Board of Directors authorized a $0.20 per share cash dividend to stockholders of record as of September 26, 2017, to be paid on October 9, 2017. This dividend represents the Company’s third quarter 2017 dividend payment to its stockholders.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a Maryland corporation engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to strong clinical operators with leading market share. The Company’s strategy is to produce increasing, reliable rental revenue by expanding its portfolio, and leasing its healthcare facilities to market-leading operators under long-term, triple-net leases. The Company’s management team has significant healthcare, real estate and public real estate investment trust, or REIT, experience and has long-established relationships with a wide range of healthcare providers. The Company intends to elect to be taxed as a REIT for U.S. federal income tax purposes, commencing with its taxable year ended December 31, 2016.

Forward-Looking Statements

This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. These risks and uncertainties are described in greater detail in the “Risk Factors” section of our Annual Report on Form 10-K, as amended by Amendment No. 2 thereto, for the year ended December 31, 2016, which were filed with the United States Securities and Exchange Commission (the “Commission”) on March 27, 2017 and May 9, 2017, respectively, and elsewhere in the reports the Company has filed with the Commission, including that the Company may be unable to pay its third quarter dividend in a timely fashion or at all. You are cautioned not to place undue reliance on forward-looking statements. Unless legally required, the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. The Company undertakes no obligation to update these statements after the date of this release.

Contacts

Investor Relations Counsel
The Equity Group Inc.
Jeremy Hellman, 212-836-9626
Senior Associate
jhellman@equityny.com
or
Adam Prior, 212-836-9606
Senior Vice President
aprior@equityny.com

Contacts

Investor Relations Counsel
The Equity Group Inc.
Jeremy Hellman, 212-836-9626
Senior Associate
jhellman@equityny.com
or
Adam Prior, 212-836-9606
Senior Vice President
aprior@equityny.com